AstraZeneca has selected an undisclosed oncology target from Regulus Therapeutics as part of their strategic alliance in order to discover, develop and commercialize microRNA therapeutics. Both the companies have entered into a strategic ...
Vernalis has reached a research milestone as part of the oncology drug discovery alliance with French pharmaceutical company, Servier. Under the drug discovery program, Vernalis will receive a payment of €0.5m from Servier on ...
Tags: drug discovery platforms, oncology drug discovery, undisclosed oncology